Loading candles…
Narayana Hrudayalaya Ltd, founded by Dr. Devi Prasad Shetty, operates in the healthcare and hospital industries. The company manages a network of multi-specialty and super specialty hospitals that offer tertiary healthcare facilities. It provides medical care across various specialties including cardiac sciences, oncology, and neurosciences. As of early 2026, Narayana Hrudayalaya manages 55 healthcare facilities with approximately 5,933 operational beds. The company serves multiple geographies including India, the Cayman Islands, and the United Kingdom.
This page is a live market overview for NARAYANA HRUDAYALAYA LTD. (NH) on the NSE. As a listed security, NARAYANA HRUDAYALAYA LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for NH before placing trades on tick2trade.
As of the latest feed, NH last traded at ₹1,885.1 on NSE, up ₹0.1 (0.01%) from the previous close of ₹1,885. Today's session range is ₹1,865.7 – ₹1,900, against a 52-week band of ₹1,589 – ₹2,093.3. Traded volume today stands at 2.33L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for NH in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether NH is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for NARAYANA HRUDAYALAYA LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in NH. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated NH option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Audited Results - Q4 & FY26 | To consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, dividend, Fund Raising and o… | 22 May 2026 |
| Unaudited Results - Q3-FY25 | To consider and approve the un-audited Standalone and ConsolidatedFinancial Results of the Company for the quarter ended December 31, 2025 | 13 Feb 2026 |
| Unaudited Results - Q2 & FY25 | To consider and approve un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025 | 14 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and Fund Raising | 1 Aug 2025 |
| Audited Results - Q4 & FY25 | NARAYANA HRUDAYALAYA LTD. has informed the Exchange about Board Meeting to be held on 23-May-2025 to consider and approve the audited standalone and consolid… | 23 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.